mTORC1 pathway in DNA damage response
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Living organisms have evolved various mechanisms to control their metabolism and response to various stresses, allowing them to survive and grow in different environments. In eukaryotes, the highly conserved mechanistic target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of cellular metabolism, proliferation and survival. A growing body of evidence indicates that mTOR signaling is closely related to another cellular protection mechanism, the DNA damage response (DDR). Many factors important for the DDR are also involved in the mTOR pathway. In this review, we discuss how these two pathways communicate to ensure an efficient protection of the cell against metabolic and genotoxic stresses. We also describe how anticancer therapies benefit from simultaneous targeting of the DDR and mTOR pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
The Role of Atg Proteins in Autophagosome Formation
Mizushima, N., Yoshimori, T., & Ohsumi, Y. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154005 · Cited by 2,978
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464
Self-consumption: the interplay of autophagy and apoptosis
Mariño, G., Niso-Santano, M., Baehrecke, E. H., & Kroemer, G. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3735 · Cited by 2,172
Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4
Scherz‐Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., & Elazar, Z. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601623 · Cited by 2,101
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886
Zoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., & Sabatini, D. M. (2011) · Science · doi:10.1126/science.1207056 · Cited by 1,673
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488
A unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236
Regulation of autophagy by cytoplasmic p53
Tasdemir, E., Maiuri, M. C., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M., D'Amelio, M., Criollo, A., Morselli, E., Zhu, C., Harper, F., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1730 · Cited by 1,132
Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Shimobayashi, M., & Hall, M. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3757 · Cited by 1,053
Rheb Binds and Regulates the mTOR Kinase
Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1
Bar-Peled, L., Schweitzer, L. D., Zoncu, R., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.07.032 · Cited by 918
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Chantranupong, L., Scaria, S. M., Saxton, R. A., Gygi, M. P., Shen, K., Wyant, G. A., Wang, T., Harper, J. W., Gygi, S. P., & Sabatini, D. M. (2016) · Cell · doi:10.1016/j.cell.2016.02.035 · Cited by 843
Morita, M., Gravel, S.-P., Chénard, V., Sikström, K., Zheng, L., Alain, T., Gandin, V., Avizonis, D., Arguello, M., Zakaria, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.001 · Cited by 842
Mitochondria are required for pro-ageing features of the senescent phenotype
Correia‐Melo, C., Marques, F. D., Anderson, R., Hewitt, G., Hewitt, R., Cole, J., Carroll, B. M., Miwa, S., Birch, J., Merz, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592862 · Cited by 796
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M., & Manning, B. D. (2016) · Science · doi:10.1126/science.aad0489 · Cited by 795
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1
Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739
Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD
Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V., & Chumakov, P. M. (2004) · Science · doi:10.1126/science.1095569 · Cited by 731
A complex interplay between Akt, TSC2 and the two mTOR complexes
Huang, J., & Manning, B. D. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370217 · Cited by 724
DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W. (2008) · Genes & Development · doi:10.1101/gad.1617608 · Cited by 710
Mitochondrial DNA mutations and human disease
Tuppen, H. A. L., Blakely, E. L., Turnbull, D. M., & Taylor, R. W. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.09.005 · Cited by 676
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Rebsamen, M., Pochini, L., Stasyk, T., de Araújo, M. E. G., Galluccio, M., Kandasamy, R. K., Snijder, B., Fauster, A., Rudashevskaya, E. L., Bruckner, M., et al. (2015) · Nature · doi:10.1038/nature14107 · Cited by 673
Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.-F., Giorgetti-Peraldi, S., & Bost, F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1769 · Cited by 616
TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
Dibble, C. C., Elis, W., Menon, S., Qin, W., Klekota, J., Asara, J. M., Finan, P. M., Kwiatkowski, D. J., Murphy, L. O., & Manning, B. D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.009 · Cited by 612
Tsun, Z.-Y., Bar-Peled, L., Chantranupong, L., Zoncu, R., Wang, T., Kim, C., Spooner, E., & Sabatini, D. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.016 · Cited by 565
mTOR coordinates protein synthesis, mitochondrial activity and proliferation
Morita, M., Gravel, S.-P., Hulea, L., Larsson, O., Pollak, M., St-Pierre, J., & Topisirovic, I. (2015) · Cell Cycle · doi:10.4161/15384101.2014.991572 · Cited by 552
Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801 , Involved in Apoptosis
Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2283-2293.2002 · Cited by 546
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Lamming, D. W., Ye, L., Sabatini, D. M., & Baur, J. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64099 · Cited by 531
Bae, S. H., Sung, S. H., Oh, S. Y., Lim, J. M., Lee, S. K., Park, Y. N., Lee, H. E., Kang, D., & Rhee, S. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.002 · Cited by 492
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Rodrik-Outmezguine, V. S., Okaniwa, M., Yao, Z., Novotny, C. J., McWhirter, C., Banaji, A., Won, H., Wong, W., Berger, M., de Stanchina, E., et al. (2016) · Nature · doi:10.1038/nature17963 · Cited by 479
Ellisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474
Chantranupong, L., Wolfson, R. L., Orozco, J. M., Saxton, R. A., Scaria, S. M., Bar-Peled, L., Spooner, E., Isasa, M., Gygi, S. P., & Sabatini, D. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.014 · Cited by 466
Dazert, E., & Hall, M. N. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.003 · Cited by 460
The utilization of extracellular proteins as nutrients is suppressed by mTORC1
Palm, W., Park, Y., Wright, K., Pavlova, N. N., Tuveson, D. A., & Thompson, C. B. (2015) · Cell · doi:10.1016/j.cell.2015.06.017 · Cited by 457
Kenzelmann Broz, D., Spano Mello, S., Bieging, K. T., Jiang, D., Dusek, R. L., Brady, C. A., Sidow, A., & Attardi, L. D. (2013) · Genes & Development · doi:10.1101/gad.212282.112 · Cited by 443
Coordinated regulation of protein synthesis and degradation by mTORC1
Zhang, Y., Nicholatos, J., Dreier, J. R., Ricoult, S. J. H., Widenmaier, S. B., Hotamisligil, G. S., Kwiatkowski, D. J., & Manning, B. D. (2014) · Nature · doi:10.1038/nature13492 · Cited by 350
Sestrins inhibit mTORC1 kinase activation through the GATOR complex
Parmigiani, A., Nourbakhsh, A., Ding, B., Wang, W., Kim, Y. C., Akopiants, K., Guan, K.-L., Karin, M., & Budanov, A. V. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.019 · Cited by 336
Translesion DNA Synthesis and Mutagenesis in Eukaryotes
Sale, J. E. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012708 · Cited by 282
Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9
Jung, J., Genau, H. M., & Behrends, C. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00125-15 · Cited by 266
mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266
Zhang, J., Kim, J., Alexander, A., Cai, S., Tripathi, D. N., Dere, R., Tee, A. R., Tait-Mulder, J., Di Nardo, A., Han, J. M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2822 · Cited by 258
Fanconi Anemia Proteins Function in Mitophagy and Immunity
Sumpter, R., Sirasanagandla, S., Fernández, Á. F., Wei, Y., Dong, X., Franco, L., Zou, Z., Marchal, C., Lee, M. Y., Clapp, D. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.006 · Cited by 250
Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex
Sarbassov, D. D., & Sabatini, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506096200 · Cited by 248
Peng, M., Yin, N., & Li, M. O. (2014) · Cell · doi:10.1016/j.cell.2014.08.038 · Cited by 220
Dunlop, E. A., Hunt, D. K., Acosta-Jaquez, H. A., Fingar, D. C., & Tee, A. R. (2011) · Autophagy · doi:10.4161/auto.7.7.15491 · Cited by 219
SZT2 dictates GATOR control of mTORC1 signalling
Peng, M., Yin, N., & Li, M. O. (2017) · Nature · doi:10.1038/nature21378 · Cited by 192
DNA Damage Response and Autophagy: A Meaningful Partnership
Eliopoulos, A. G., Havaki, S., & Gorgoulis, V. G. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00204 · Cited by 169
REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling
Dennis, M. D., Coleman, C. S., Berg, A., Jefferson, L. S., & Kimball, S. R. (2014) · Science Signaling · doi:10.1126/scisignal.2005103 · Cited by 159
The role of tumor suppressor p53 in the antioxidant defense and metabolism
Budanov, A. V. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_18 · Cited by 157
Neklesa, T. K., & Davis, R. W. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000515 · Cited by 151
Dietary restriction.; mitochondrial function and aging: From yeast to humans
Ruetenik, A., & Barrientos, A. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.005 · Cited by 139
Targeting the SASP to combat ageing: Mitochondria as possible intracellular allies?
Birch, J., & Passos, J. F. (2017) · BioEssays · doi:10.1002/bies.201600235 · Cited by 89
Jazwinski, S. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00005-2 · Cited by 67
Zhao, B., Shah, P., Budanov, A. V., Qiang, L., Ming, M., Aplin, A., Sims, D. M., & He, Y.-Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595397 · Cited by 61
Zhao, B., Shah, P., Qiang, L., He, T., Budanov, A., & He, Y. (2017) · Photochemistry and Photobiology · doi:10.1111/php.12624 · Cited by 44
Research works printed but not linked: 153
- Loewith, 2011, Target of rapamycin (TOR) in nutrient signaling and growth control, Genetics, 189, 1177, 10.1534/genetics.111.133363 · DOI · Paper page
- Betz, 2013, Where is mTOR and what is it doing there?, J. Cell Biol., 203, 563, 10.1083/jcb.201306041 · DOI · Paper page
- Gingras, 1999, Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism, Genes Dev., 13, 1422, 10.1101/gad.13.11.1422 · DOI · Paper page
- Poulin, 1998, 4E-BP3, a new member of the eukaryotic initiation factor 4E-binding protein family, J. Biol. Chem., 273, 14002, 10.1074/jbc.273.22.14002 · DOI · Paper page
- Robitaille, 2013, Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis, Science, 339, 1320, 10.1126/science.1228771 · DOI · Paper page
- Porstmann, 2008, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth, Cell Metab., 8, 224, 10.1016/j.cmet.2008.07.007 · DOI · Paper page
- Peterson, 2011, mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway, Cell, 146, 408, 10.1016/j.cell.2011.06.034 · DOI · Paper page
- Rousseau, 2016, An evolutionarily conserved pathway controls proteasome homeostasis, Nature, 536, 184, 10.1038/nature18943 · DOI · Paper page
- Zhao, 2015, mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy, Proc. Natl. Acad. Sci. U. S. A., 112, 15790, 10.1073/pnas.1521919112 · DOI · Paper page
- Zhao, 2016, Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR, Autophagy, 12, 1967, 10.1080/15548627.2016.1205770 · DOI
- Yin, 2016, Autophagy: machinery and regulation, Microb. Cell, 3, 588, 10.15698/mic2016.12.546 · DOI · Paper page
- Saxton, 2016, Mechanism of arginine sensing by CASTOR1 upstream of mTORC1, Nature, 536, 229, 10.1038/nature19079 · DOI · Paper page
- Wang, 2015, Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1, Science, 347, 188, 10.1126/science.1257132 · DOI · Paper page
- Wyant, 2017, mTORC1 activator SLC38A9 is required to efflux essential amino acids from lysosomes and use protein as a nutrient, Cell, 171, 642, 10.1016/j.cell.2017.09.046 · DOI · Paper page
- Gu, 2017, SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway, Science, 358, 813, 10.1126/science.aao3265 · DOI · Paper page
- Wolfson, 2017, KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1, Nature, 543, 438, 10.1038/nature21423 · DOI · Paper page
- Kim, 2012, SH3BP4 is a negative regulator of amino acid-Rag GTPase-mTORC1 signaling, Mol. Cell, 46, 833, 10.1016/j.molcel.2012.04.007 · DOI · Paper page
- Han, 2012, Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway, Cell, 149, 410, 10.1016/j.cell.2012.02.044 · DOI · Paper page
- Villanueva-Paz, 2016, AMPK regulation of cell growth, apoptosis, autophagy, and bioenergetics, EXS, 107, 45
- Parmigiani, 2016, Sensing the environment through sestrins: implications for cellular metabolism, Int. Rev. Cell Mol. Biol., 327, 1, 10.1016/bs.ircmb.2016.05.003 · DOI
- Eker, 2009, DNA repair in mammalian cells: direct DNA damage reversal: elegant solutions for nasty problems, Cell. Mol. Life Sci., 66, 968, 10.1007/s00018-009-8735-0 · DOI
- Reyes, 2015, New insights into the mechanism of DNA mismatch repair, Chromosoma, 124, 443, 10.1007/s00412-015-0514-0 · DOI
- Whitaker, 2017, Base excision repair of oxidative DNA damage: from mechanism to disease, Front. Biosci., 22, 1493, 10.2741/4555 · DOI · Paper page
- Scharer, 2013, Nucleotide excision repair in eukaryotes, Cold Spring Harb. Perspect. Biol., 5, a012609, 10.1101/cshperspect.a012609 · DOI · Paper page
- Chapman, 2012, Playing the end game: DNA double-strand break repair pathway choice, Mol. Cell, 47, 497, 10.1016/j.molcel.2012.07.029 · DOI · Paper page
- Bhargava, 2016, Regulation of single-strand annealing and its role in genome maintenance, Trends Genet., 32, 566, 10.1016/j.tig.2016.06.007 · DOI · Paper page
- Rodriguez-Vargas, 2012, ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy, Cell Res., 22, 1181, 10.1038/cr.2012.70 · DOI · Paper page
- Munoz-Gamez, 2009, PARP-1 is involved in autophagy induced by DNA damage, Autophagy, 5, 61, 10.4161/auto.5.1.7272 · DOI · Paper page
- Paull, 2015, Mechanisms of ATM activation, Annu. Rev. Biochem., 84, 711, 10.1146/annurev-biochem-060614-034335 · DOI · Paper page
- Alexander, 2010, ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS, Proc. Natl. Acad. Sci. U. S. A., 107, 4153, 10.1073/pnas.0913860107 · DOI · Paper page
- Zhang, 2015, ATM functions at the peroxisome to induce pexophagy in response to ROS, Nat. Cell Biol., 17, 1259, 10.1038/ncb3230 · DOI · Paper page
- Kim, 2002, Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage, Genes Dev., 16, 560, 10.1101/gad.970602 · DOI · Paper page
- Tsai, 2008, Functional interaction between FOXO3a and ATM regulates DNA damage response, Nat. Cell Biol., 10, 460, 10.1038/ncb1709 · DOI · Paper page
- Zhao, 2011, AMPK-dependent phosphorylation of ULK1 induces autophagy, Cell Metab., 13, 119, 10.1016/j.cmet.2011.01.009 · DOI · Paper page
- Selvarajah, 2015, DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1, Oncotarget, 6, 427, 10.18632/oncotarget.2813 · DOI
- Ma, 2017, Tumor suppressor NPRL2 induces ROS production and DNA damage response, Sci. Rep., 7, 15311, 10.1038/s41598-017-15497-0 · DOI
- Shen, 2013, The mTOR pathway negatively controls ATM by up-regulating miRNAs, Proc. Natl. Acad. Sci. U. S. A., 110, 11869, 10.1073/pnas.1220898110 · DOI · Paper page
- Zhou, 2017, Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells, Sci. Rep., 7, 1535, 10.1038/s41598-017-01729-w · DOI
- Xie, 2018, The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168, Nat. Cell Biol., 20, 320, 10.1038/s41556-017-0033-8 · DOI · Paper page
- Li, 2013, Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation, J. Biol. Chem., 288, 13215, 10.1074/jbc.M113.463679 · DOI
- Dey, 2015, High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression, Cell. Signal., 27, 1276, 10.1016/j.cellsig.2015.03.007 · DOI
- Franke, 1997, Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate, Science, 275, 665, 10.1126/science.275.5300.665 · DOI · Paper page
- Alessi, 1996, Mechanism of activation of protein kinase B by insulin and IGF-1, EMBO J., 15, 6541, 10.1002/j.1460-2075.1996.tb01045.x · DOI · Paper page
- Xu, 2012, Akt: a double-edged sword in cell proliferation and genome stability, J. Oncol., 2012, 951724, 10.1155/2012/951724 · DOI · Paper page
- Kovacina, 2003, Identification of a proline-rich Akt substrate as a 14-3-3 binding partner, J. Biol. Chem., 278, 10189, 10.1074/jbc.M210837200 · DOI · Paper page
- Thedieck, 2007, PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis, PLoS One, 2, e1217, 10.1371/journal.pone.0001217 · DOI · Paper page
- Vander Haar, 2007, Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40, Nat. Cell Biol., 9, 316, 10.1038/ncb1547 · DOI · Paper page
- Yu, 2011, Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling, Science, 332, 1322, 10.1126/science.1199484 · DOI · Paper page
- Leslie, 2004, PTEN function: how normal cells control it and tumour cells lose it, Biochem. J., 382, 1, 10.1042/BJ20040825 · DOI · Paper page
- Viniegra, 2005, Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM, J. Biol. Chem., 280, 4029, 10.1074/jbc.M410344200 · DOI · Paper page
- Caporali, 2008, AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition, Mol. Pharmacol., 74, 173, 10.1124/mol.107.044743 · DOI
- Bozulic, 2008, PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival, Mol. Cell, 30, 203, 10.1016/j.molcel.2008.02.024 · DOI · Paper page
- Kandel, 2002, Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage, Mol. Cell. Biol., 22, 7831, 10.1128/MCB.22.22.7831-7841.2002 · DOI · Paper page
- Toulany, 2006, Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair, Clin. Cancer Res., 12, 4119, 10.1158/1078-0432.CCR-05-2454 · DOI · Paper page
- Kao, 2007, Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation, J. Biol. Chem., 282, 21206, 10.1074/jbc.M703042200 · DOI · Paper page
- Toulany, 2008, Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair, Mol. Cancer Ther., 7, 1772, 10.1158/1535-7163.MCT-07-2200 · DOI · Paper page
- Toulany, 2012, Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair, Mol. Cancer Res., 10, 945, 10.1158/1541-7786.MCR-11-0592 · DOI · Paper page
- Holler, 2016, Dual targeting of Akt and mTORC1 impairs repair of DNA double-strand breaks and increases radiation sensitivity of human tumor cells, PLoS One, 11, e0154745, 10.1371/journal.pone.0154745 · DOI
- Cam, 2014, p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage, J. Biol. Chem., 289, 4083, 10.1074/jbc.M113.530303 · DOI · Paper page
- Piscitello, 2017, AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11, Oncogene, 37, 427, 10.1038/onc.2017.340 · DOI
- Workman, 2014, Environmental signaling through the mechanistic target of rapamycin complex 1: mTORC1 goes nuclear, Cell Cycle, 13, 714, 10.4161/cc.28112 · DOI
- Giguere, 2018, Canonical signaling and nuclear activity of mTOR-a teamwork effort to regulate metabolism and cell growth, FEBS J., 285, 1572, 10.1111/febs.14384 · DOI
- Vega-Rubin-de-Celis, 2017, Multistep regulation of TFEB by MTORC1, Autophagy, 13, 464, 10.1080/15548627.2016.1271514 · DOI · Paper page
- Bertram, 2000, Tripartite regulation of Gln3p by TOR, Ure2p, and phosphatases, J. Biol. Chem., 275, 35727, 10.1074/jbc.M004235200 · DOI · Paper page
- Roczniak-Ferguson, 2012, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis, Sci. Signal., 5, ra42, 10.1126/scisignal.2002790 · DOI · Paper page
- Settembre, 2012, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, EMBO J., 31, 1095, 10.1038/emboj.2012.32 · DOI · Paper page
- Matsushita, 2011, Direct inhibition of TNF-alpha promoter activity by Fanconi anemia protein FANCD2, PLoS One, 6, e23324, 10.1371/journal.pone.0023324 · DOI
- Palovcak, 2017, Maintenance of genome stability by Fanconi anemia proteins, Cell Biosci., 7, 8, 10.1186/s13578-016-0134-2 · DOI
- Guo, 2013, mTOR regulates DNA damage response through NF-kappaB-mediated FANCD2 pathway in hematopoietic cells, Leukemia, 27, 2040, 10.1038/leu.2013.93 · DOI
- Shen, 2013, Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks, Cancer Res., 73, 3393, 10.1158/0008-5472.CAN-12-4282 · DOI
- Chaveroux, 2013, Molecular and genetic crosstalks between mTOR and ERRalpha are key determinants of rapamycin-induced nonalcoholic fatty liver, Cell Metab., 17, 586, 10.1016/j.cmet.2013.03.003 · DOI
- Audet-Walsh, 2017, Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer, Genes Dev., 31, 1228, 10.1101/gad.299958.117 · DOI
- Vazquez-Martin, 2011, Raptor, a positive regulatory subunit of mTOR complex 1, is a novel phosphoprotein of the rDNA transcription machinery in nucleoli and chromosomal nucleolus organizer regions (NORs), Cell Cycle, 10, 3140, 10.4161/cc.10.18.17376 · DOI
- Yadav, 2013, mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging, BMC Cell Biol., 14, 3, 10.1186/1471-2121-14-3 · DOI · Paper page
- Grove, 2017, Control of RNA polymerase II-transcribed genes by direct binding of TOR kinase, Curr. Genet., 64, 131, 10.1007/s00294-017-0738-z · DOI
- Panday, 2017, DNA damage regulates direct association of TOR kinase with the RNA polymerase II-transcribed HMO1 gene, Mol. Biol. Cell, 28, 2449, 10.1091/mbc.e17-01-0024 · DOI
- Kasahara, 2011, Hmo1 directs pre-initiation complex assembly to an appropriate site on its target gene promoters by masking a nucleosome-free region, Nucleic Acids Res., 39, 4136, 10.1093/nar/gkq1334 · DOI
- Panday, 2015, Yeast high mobility group protein HMO1 stabilizes chromatin and is evicted during repair of DNA double strand breaks, Nucleic Acids Res., 43, 5759, 10.1093/nar/gkv498 · DOI
- Whitney, 2009, ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression, Biochem. Biophys. Res. Commun., 379, 451, 10.1016/j.bbrc.2008.12.079 · DOI · Paper page
- Qiao, 2015, A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity, Nat. Commun., 6, 7014, 10.1038/ncomms8014 · DOI · Paper page
- Regazzetti, 2012, Regulated in development and DNA damage responses −1 (REDD1) protein contributes to insulin signaling pathway in adipocytes, PLoS One, 7, e52154, 10.1371/journal.pone.0052154 · DOI
- Dungan, 2017, Regulation of skeletal muscle insulin-stimulated signaling through the MEK-REDD1-mTOR axis, Biochem. Biophys. Res. Commun., 482, 1067, 10.1016/j.bbrc.2016.11.159 · DOI
- Dennis, 2013, Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1), Cell. Signal., 25, 2709, 10.1016/j.cellsig.2013.08.038 · DOI
- Pastor, 2017, Implication of REDD1 in the activation of inflammatory pathways, Sci. Rep., 7, 7023, 10.1038/s41598-017-07182-z · DOI
- Horak, 2010, Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis, Proc. Natl. Acad. Sci. U. S. A., 107, 4675, 10.1073/pnas.0907705107 · DOI · Paper page
- Czarny, 2015, Autophagy in DNA damage response, Int. J. Mol. Sci., 16, 2641, 10.3390/ijms16022641 · DOI · Paper page
- Hasty, 2013, mTORC1 and p53: clash of the gods?, Cell Cycle, 12, 20, 10.4161/cc.22912 · DOI · Paper page
- Lai, 2010, S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response, EMBO J., 29, 2994, 10.1038/emboj.2010.166 · DOI
- Hu, 2012, The regulation of multiple p53 stress responses is mediated through MDM2, Genes Cancer, 3, 199, 10.1177/1947601912454734 · DOI · Paper page
- Budanov, 2002, Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability, Oncogene, 21, 6017, 10.1038/sj.onc.1205877 · DOI · Paper page
- Feng, 2005, The coordinate regulation of the p53 and mTOR pathways in cells, Proc. Natl. Acad. Sci. U. S. A., 102, 8204, 10.1073/pnas.0502857102 · DOI · Paper page
- Zhang, 2003, Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR, J. Clin. Invest., 112, 1223, 10.1172/JCI200317222 · DOI
- Shin, 2012, Nrf2-ARE pathway regulates induction of Sestrin-2 expression, Free Radic. Biol. Med., 53, 834, 10.1016/j.freeradbiomed.2012.06.026 · DOI · Paper page
- Ye, 2015, GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2, Genes Dev., 29, 2331, 10.1101/gad.269324.115 · DOI · Paper page
- Zhang, 2013, Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells, Cell. Signal., 25, 150, 10.1016/j.cellsig.2012.09.004 · DOI
- Sanli, 2012, Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells, PLoS One, 7, 10.1371/journal.pone.0032035 · DOI · Paper page
- Ben-Sahra, 2013, Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death, Cell Death Differ., 20, 611, 10.1038/cdd.2012.157 · DOI
- Dokudovskaya, 2015, SEA you later alli-GATOR - a dynamic regulator of the TORC1 stress response pathway, J. Cell Sci., 128, 2219, 10.1242/jcs.168922 · DOI · Paper page
- Li, 2004, Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C, Cancer Res., 64, 6438, 10.1158/0008-5472.CAN-03-3869 · DOI · Paper page
- Otani, 2009, The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor, J. Surg. Oncol., 100, 358, 10.1002/jso.21241 · DOI
- Ueda, 2006, The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells, Cancer Res., 66, 9682, 10.1158/0008-5472.CAN-06-1483 · DOI
- Jayachandran, 2010, NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway, PLoS One, 5, e11994, 10.1371/journal.pone.0011994 · DOI
- Algret, 2014, Molecular architecture and function of the SEA complex, a modulator of the TORC1 pathway, Mol. Cell. Proteomics, 13, 2855, 10.1074/mcp.M114.039388 · DOI · Paper page
- Dokudovskaya, 2011, A conserved coatomer-related complex containing Sec13 and Seh1 dynamically associates with the vacuole in Saccharomyces cerevisiae, Mol. Cell. Proteomics, 10, 006478
- Panchaud, 2013, SEACing the GAP that nEGOCiates TORC1 activation: evolutionary conservation of Rag GTPase regulation, Cell Cycle, 12, 1, 10.4161/cc.26000 · DOI · Paper page
- Sutter, 2013, Methionine inhibits autophagy and promotes growth by inducing the SAM-responsive methylation of PP2A, Cell, 154, 403, 10.1016/j.cell.2013.06.041 · DOI · Paper page
- Tate, 2013, Five conditions commonly used to down regulate TorC1 generate different physiological situations exhibiting distinct requirements and outcomes, J. Biol. Chem., 288, 27243, 10.1074/jbc.M113.484386 · DOI
- Hughes Hallett, 2014, State transitions in the TORC1 signaling pathway and information processing in Saccharomyces cerevisiae, Genetics, 198, 773, 10.1534/genetics.114.168369 · DOI · Paper page
- Goodarzi, 2004, Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A, EMBO J., 23, 4451, 10.1038/sj.emboj.7600455 · DOI · Paper page
- Dozier, 2004, Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B' regulatory subunit, Biol. Cell, 96, 509, 10.1016/j.biolcel.2004.04.010 · DOI · Paper page
- Ferrari, 2017, PP2A controls genome integrity by integrating nutrient-sensing and metabolic pathways with the DNA damage response, Mol. Cell, 67, 266, 10.1016/j.molcel.2017.05.027 · DOI
- Turcotte, 2010, Targeting cancer cells through autophagy for anticancer therapy, Curr. Opin. Cell Biol., 22, 246, 10.1016/j.ceb.2009.12.007 · DOI
- Dalby, 2010, Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer, Autophagy, 6, 322, 10.4161/auto.6.3.11625 · DOI · Paper page
- Gomes, 2017, Autophagy roles in the modulation of DNA repair pathways, Int. J. Mol. Sci., 18, 10.3390/ijms18112351 · DOI
- Dunlop, 2014, mTOR and autophagy: a dynamic relationship governed by nutrients and energy, Semin. Cell Dev. Biol., 36, 121, 10.1016/j.semcdb.2014.08.006 · DOI · Paper page
- Martina, 2012, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB, Autophagy, 8, 903, 10.4161/auto.19653 · DOI · Paper page
- Morselli, 2011, p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200, Cell Cycle, 10, 2763, 10.4161/cc.10.16.16868 · DOI · Paper page
- Maiuri, 2009, Stimulation of autophagy by the p53 target gene Sestrin2, Cell Cycle, 8, 1571, 10.4161/cc.8.10.8498 · DOI · Paper page
- Anderson, 1981, Sequence and organization of the human mitochondrial genome, Nature, 290, 457, 10.1038/290457a0 · DOI · Paper page
- Saki, 2017, DNA damage related crosstalk between the nucleus and mitochondria, Free Radic. Biol. Med., 107, 216, 10.1016/j.freeradbiomed.2016.11.050 · DOI · Paper page
- Alexeyev, 2013, The maintenance of mitochondrial DNA integrity–critical analysis and update, Cold Spring Harb. Perspect. Biol., 5, a012641, 10.1101/cshperspect.a012641 · DOI · Paper page
- King, 1989, Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation, Science, 246, 500, 10.1126/science.2814477 · DOI · Paper page
- Alexeyev, 2008, Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes, Gene Ther., 15, 516, 10.1038/gt.2008.11 · DOI
- Ding, 2010, Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming, J. Biol. Chem., 285, 27879, 10.1074/jbc.M110.119537 · DOI · Paper page
- Li, 2010, Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling, Cell. Signal., 22, 1469, 10.1016/j.cellsig.2010.05.015 · DOI
- Yoshida, 2011, Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway, J. Biol. Chem., 286, 32651, 10.1074/jbc.M111.238014 · DOI · Paper page
- Tang, 2013, Atg9 interacts with dTRAF2/TRAF6 to regulate oxidative stress-induced JNK activation and autophagy induction, Dev. Cell, 27, 489, 10.1016/j.devcel.2013.10.017 · DOI
- Ryter, 2013, Regulation of autophagy in oxygen-dependent cellular stress, Curr. Pharm. Des., 19, 2747, 10.2174/1381612811319150010 · DOI
- Kawagishi, 2014, Unraveling the truth about antioxidants: ROS and disease: finding the right balance, Nat. Med., 20, 711, 10.1038/nm.3625 · DOI
- Ding, 2016, Sestrin2 is induced by glucose starvation via the unfolded protein response and protects cells from non-canonical necroptotic cell death, Sci. Rep., 6
- Kim, 2015, Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains, Nat. Commun., 6, 10025, 10.1038/ncomms10025 · DOI · Paper page
- Rinaldi, 2017, Mitochondrial AKAP1 supports mTOR pathway and tumor growth, Cell Death Dis., 8, e2842, 10.1038/cddis.2017.241 · DOI
- Ke, 2018, Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism, Cell Biol. Int., 42, 384, 10.1002/cbin.10915 · DOI · Paper page
- Canto, 2011, Calorie restriction: is AMPK a key sensor and effector?, Physiology (Bethesda), 26, 214
- Ho, 2013, SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK, Aging, 5, 835, 10.18632/aging.100616 · DOI · Paper page
- Liko, 2015, mTOR in health and in sickness, J. Mol. Med., 93, 1061, 10.1007/s00109-015-1326-7 · DOI
- Guri, 2016, mTOR signaling confers resistance to targeted cancer drugs, Trends Cancer, 2, 688, 10.1016/j.trecan.2016.10.006 · DOI
- Plo, 2008, AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51, Cancer Res., 68, 9404, 10.1158/0008-5472.CAN-08-0861 · DOI
- Beuvink, 2005, The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation, Cell, 120, 747, 10.1016/j.cell.2004.12.040 · DOI · Paper page
- Choo, 2008, Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation, Proc. Natl. Acad. Sci. U. S. A., 105, 17414, 10.1073/pnas.0809136105 · DOI · Paper page
- Choo, 2009, Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy, Cell Cycle, 8, 567, 10.4161/cc.8.4.7659 · DOI · Paper page
- Liu, 2013, Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR, Cancer Res., 73, 2574, 10.1158/0008-5472.CAN-12-1702 · DOI · Paper page
- Silvera, 2017, mTORC1 and −2 coordinate transcriptional and translational reprogramming in resistance to DNA damage and replicative stress in breast cancer cells, Mol. Cell. Biol., 37, 10.1128/MCB.00577-16 · DOI
- Fan, 2017, Targeted to mTORC1 drives regression in glioblastoma, Cancer cell, 31, 424, 10.1016/j.ccell.2017.01.014 · DOI · Paper page
- Tsuji, 2017, CC-115, a dual inhibitor of mTOR kinase and DNA-PK, blocks DNA damage repair pathways and selectively inhibits ATM-deficient cell growth in vitro, Oncotarget, 8, 74688, 10.18632/oncotarget.20342 · DOI
- Gil del Alcazar, 2014, Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma, Clin. Cancer Res., 20, 1235, 10.1158/1078-0432.CCR-13-1607 · DOI · Paper page
- Tsoli, 2018, Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma, Oncotarget, 9, 7541, 10.18632/oncotarget.24045 · DOI
- Kaplan, 2014, Strategies for the management of adverse events associated with mTOR inhibitors, Transplant. Rev. (Orlando), 28, 126, 10.1016/j.trre.2014.03.002 · DOI · Paper page
- Naing, 2012, Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma, Br. J. Cancer, 107, 1093, 10.1038/bjc.2012.368 · DOI · Paper page
- Mateo, 2016, A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies, Br. J. Cancer, 114, 889, 10.1038/bjc.2016.59 · DOI · Paper page
- Mahoney, 2018, A small molecule inhibitor of Rheb selectively targets mTORC1 signaling, Nat. Commun., 9, 548, 10.1038/s41467-018-03035-z · DOI · Paper page
- Kasznicki, 2014, Metformin in cancer prevention and therapy, Ann. Transl. Med., 2, 57
- Chae, 2016, Repurposing metformin for cancer treatment: current clinical studies, Oncotarget, 7, 40767, 10.18632/oncotarget.8194 · DOI · Paper page
Cited by
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
Marchetti, C., De Felice, F., Romito, A., Iacobelli, V., Sassu, C. M., Corrado, G., Ricci, C., Scambia, G., & Fagotti, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.08.011 · Cited by 139
Combination Strategies to Improve Targeted Radionuclide Therapy
Chan, T. G., O’Neill, E., Habjan, C., & Cornelissen, B. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.248062 · Cited by 91
“mTOR is also known to influence DDR; for example, mTOR can positively and negatively regulate ataxia telangiectasia mutated (57).”
BackgroundBirkisdóttir, M. B., Jaarsma, D., Brandt, R. M. C., Barnhoorn, S., van Vliet, N., Imholz, S., van Oostrom, C. T., Nagarajah, B., Portilla Fernández, E., Roks, A. J. M., et al. (2021) · Aging Cell · doi:10.1111/acel.13302 · Cited by 35
ATR promotes mTORC1 activity via de novo cholesterol synthesis
Tangudu, N. K., Grumet, A. N., Fang, R., Buj, R., Cole, A. R., Uboveja, A., Amalric, A., Yang, B., Huang, Z., Happe, C., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00451-3 · Cited by 5
Metadata
- Authors
- Ma, Y., Vassetzky, Y., & Dokudovskaya, S.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 1865
- Issue
- 9
- Pages
- 1293-1311
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2809388751
- Cited by
- 154
- References
- 80
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
- Funders
- AFM
- INSERM
- LNCC (M27231)
- ANRS
- PICS
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.